Several mid-stage trials will read out in 2025 to provide important proof points for novel MoAs and their potential for differentiation, e.g., Lillys bimagrumab (activin/myostatin type II receptor inhibitor) in combination with semaglutide, aiming to deliver weight loss while preserving muscle mass (phase 2b)
Additionally, carnitine has shown protective properties against hypertension, hyperlipidemia, hyperglycemia, diabetic ketoacidosis, insulin resistance, insulin-dependent diabetes mellitus, obesity, and other conditions that enhance cardiovascular pathology
Less common side effects may include headache, dizziness, and allergic reactions such as rash or pruritus
Though, some anecdotal reports have suggested adverse side effects including nausea, vomiting, diarrhea, and allergic reactions (e.g., skin rash)
Activit physique modre : marches dynamiques, un peu de renforcement musculaire, danse sans tomber dans lexcs de sport intensif sans rcupration